课题基金 / 基金详情

Inhibitory effects of membraneous beparin binding EGF like Factor on the apoptosis.

Inhibitory effects of membraneous beparin binding EGF like Factor on the apoptosis.
膜质beparin结合EGF样因子对细胞凋亡的抑制作用。
批准号:
11670453
负责人:
MATSUYAMA Takami
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MATSUYAMA Takami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1 HB-EGF was expressed in synovial fibroblasts from rheumatoid and osteoarthritis patients in addition to synovial macrophages by the analysis of RT-PCR and in situ hybridization using HB-EGF antisense RNA probe.2 Raji cells transfected with HB-EGF did not affect the apoptosis of Jurkat cells, compared to the wild type Raji cells. However, Heparan sulfate but no chondroitin sulfate inhibited the apoptosis of Jurkat cells, suggesting the inhibitory effect of heparan sulfate binding substance on the apoptosis of Jurkat cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapy targeting folate receptor beta expressing macrophages in chronic inflammation
  • 批准号:
    23591441
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.49万
  • 财政年份:
    2011
  • 负责人:
    MATSUYAMA Takami
  • 依托单位:
A preclinical study using recombinant anti-folate receptor-beta immunotoxin for the treatment of rheumatoid arthritis
  • 批准号:
    17591051
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.37万
  • 财政年份:
    2005
  • 负责人:
    MATSUYAMA Takami
  • 依托单位:
The diagnostic and pathological significance of soluble CD163 in rheumatoid arthritis
  • 批准号:
    13670464
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2001
  • 负责人:
    MATSUYAMA Takami
  • 依托单位:
Mechanisms of the anergy of T cells induced by varient types of soluble VCAM-1
  • 批准号:
    09670483
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.73万
  • 财政年份:
    1997
  • 负责人:
    MATSUYAMA Takami
  • 依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data